Part 6: U.S. gov’t allows Big Pharma giant to define Lyme diagnosis Journalist Suzan Erem reported on facts about a 1994 meeting between pharmaceutical giant SmithKline Beecham, the U.S. Food and Drug Administration (F - Pharmaceutical drug - Document - PDFSEARCH.IO

First Page	Meta Content
	Part 6: U.S. gov’t allows Big Pharma giant to define Lyme diagnosis Journalist Suzan Erem reported on facts about a 1994 meeting between pharmaceutical giant SmithKline Beecham, the U.S. Food and Drug Administration (F Add to Reading List Document Date: 2011-08-25 17:57:23 Open Document File Size: 55,15 KB Share Result on Facebook City Dearborn / / Company GlaxoSmithKline / SmithKline Beecham / / Country United States / / Event FDA Phase / / IndustryTerm pharmaceutical giant / / MedicalCondition disease / / MedicalTreatment antibiotics / / Organization Lyme / Lyme Disease Association / U.S. Food and Drug Administration / / Person Stanley Plotkin / Suzan Erem / Wikipedia / Allen Steere / / Position diagnosis Journalist / / Product Lyme vaccine / / ProvinceOrState Michigan / / SocialTag Health Lyme disease Allen Steere Rheumatologists Year of birth missing Vaccines Beecham Smith, Kline & French Medicine GlaxoSmithKline

Part 6: U.S. gov’t allows Big Pharma giant to define Lyme diagnosis Journalist Suzan Erem reported on facts about a 1994 meeting between pharmaceutical giant SmithKline Beecham, the U.S. Food and Drug Administration (FAdd to Reading List